313 related articles for article (PubMed ID: 32220105)
21. Prospective Validation of Vesical Imaging-Reporting and Data System Using a Next-Generation Magnetic Resonance Imaging Scanner-Is Denoising Deep Learning Reconstruction Useful?
Taguchi S; Tambo M; Watanabe M; Machida H; Kariyasu T; Fukushima K; Shimizu Y; Okegawa T; Yokoyama K; Fukuhara H
J Urol; 2021 Mar; 205(3):686-692. PubMed ID: 33021428
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
[TBL] [Abstract][Full Text] [Related]
23. VI-RADS score and tumor contact length in MRI: A potential method for the detection of muscle invasion in bladder cancer.
Akcay A; Yagci AB; Celen S; Ozlulerden Y; Turk NS; Ufuk F
Clin Imaging; 2021 Sep; 77():25-36. PubMed ID: 33639497
[TBL] [Abstract][Full Text] [Related]
24. Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study.
Marchioni M; Primiceri G; Delli Pizzi A; Basilico R; Berardinelli F; Mincuzzi E; Castellucci R; Sessa B; Di Nicola M; Schips L
Clin Genitourin Cancer; 2020 Oct; 18(5):409-415.e1. PubMed ID: 32273236
[TBL] [Abstract][Full Text] [Related]
25. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
[TBL] [Abstract][Full Text] [Related]
26. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
[TBL] [Abstract][Full Text] [Related]
27. Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field.
Watanabe M; Taguchi S; Machida H; Tambo M; Takeshita Y; Kariyasu T; Fukushima K; Shimizu Y; Okegawa T; Fukuhara H; Yokoyama K
Eur Radiol; 2022 Nov; 32(11):7513-7521. PubMed ID: 35554648
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: A systematic review and diagnostic meta-analysis.
Jazayeri SB; Dehghanbanadaki H; Hosseini M; Taghipour P; Alam MU; Balaji KC; Bandyk M
Urol Oncol; 2022 Feb; 40(2):45-55. PubMed ID: 34895996
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion.
Wang H; Luo C; Zhang F; Guan J; Li S; Yao H; Chen J; Luo J; Chen L; Guo Y
Radiology; 2019 Jun; 291(3):668-674. PubMed ID: 31012814
[TBL] [Abstract][Full Text] [Related]
30. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
Chai JL; Roller LA; Liu X; Lan Z; Mossanen M; Silverman SG; Shinagare AB
Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214
[TBL] [Abstract][Full Text] [Related]
31. Accuracy and Challenges in the Vesical Imaging-Reporting and Data System for Staging Bladder Cancer.
Meng X; Hu H; Wang Y; Feng C; Hu D; Liu Z; Kamel IR; Li Z
J Magn Reson Imaging; 2022 Aug; 56(2):391-398. PubMed ID: 35049074
[TBL] [Abstract][Full Text] [Related]
32. Combining volumetric apparent diffusion coefficient histogram analysis with vesical imaging reporting and data system to predict the muscle invasion of bladder cancer.
Li S; Liang P; Wang Y; Feng C; Shen Y; Hu X; Hu D; Meng X; Li Z
Abdom Radiol (NY); 2021 Sep; 46(9):4301-4310. PubMed ID: 33909091
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer.
Elshetry ASF; El-Fawakry RM; Hamed EM; Metwally MI; Zaid NA
Eur J Radiol; 2022 Jun; 151():110282. PubMed ID: 35381566
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic validity of the vesical imaging-reporting and data system (VI-RADS): a real-world study.
Kazan O; Gunduz N; Bakir B; Iplikci A; Culpan M; Ersoy B; Yildirim A
Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):638-644. PubMed ID: 37209783
[TBL] [Abstract][Full Text] [Related]
35. Validation of vesical imaging reporting and data system for assessing muscle invasion in bladder tumor.
Kim SH
Abdom Radiol (NY); 2020 Feb; 45(2):491-498. PubMed ID: 31422440
[TBL] [Abstract][Full Text] [Related]
36. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).
Panebianco V; Narumi Y; Altun E; Bochner BH; Efstathiou JA; Hafeez S; Huddart R; Kennish S; Lerner S; Montironi R; Muglia VF; Salomon G; Thomas S; Vargas HA; Witjes JA; Takeuchi M; Barentsz J; Catto JWF
Eur Urol; 2018 Sep; 74(3):294-306. PubMed ID: 29755006
[TBL] [Abstract][Full Text] [Related]
37. A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.
Bicchetti M; Simone G; Giannarini G; Girometti R; Briganti A; Brunocilla E; Cardone G; De Cobelli F; Gaudiano C; Del Giudice F; Flammia S; Leonardo C; Pecoraro M; Schiavina R; Catalano C; Panebianco V
Radiol Med; 2022 Aug; 127(8):881-890. PubMed ID: 35763251
[TBL] [Abstract][Full Text] [Related]
38. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
39. Prospective assessment of VI-RADS score in multiparametric MRI in bladder cancer: accuracy and the factors affecting the results.
Oğuz U; Bekçi T; Öğreden E; Aslan S; Duman A; Demirelli E; Şengül D; Tok DS; Çiftçi OÇ; Tosun A
Diagn Interv Radiol; 2022 Sep; 28(5):396-402. PubMed ID: 35997477
[TBL] [Abstract][Full Text] [Related]
40. Multiparametric MRI Evaluation of VI-RADS for Bladder Tumors Located at the Ureteral Orifice.
Cai Q; Ling J; Kong L; Huang Y; Lin Y; Wen Z; Li M; Guo Y; Wang H
Radiology; 2022 Sep; 304(3):593-599. PubMed ID: 35670714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
